GL1X · GenesisL1 explorer

Research workbench

ROS1 with astrazeneca ligand 2

Analyse ROS1 with astrazeneca ligand 2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7Z5X
Type
protein
Length
541 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase ROS
EC
2.7.10.1
UniProt
P08922
Ligands
AWJ
Pockets
5 · best druggability 0.58

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1)protein27042% helix, 17% strandP08922
BProto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1)protein27142% helix, 17% strandP08922

Ligands and binding sites

  • AWJ · (2R)-2-[5-(6-amino-5-{(1R)-1-[2-(1,3-dihydro-2H-1,2,3-triazol-2-yl)-5-fluorophenyl]ethoxy}pyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]propane-1,2-diol · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12300.580.7928AWJ
22250.570.7824AWJ
32220.480.7426empty
41520.420.7419empty
5550.300.7516empty

Interfaces

1 interface between chains.

  • A–B · 684 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 7Z5X · ROS1 with AstraZeneca ligand 2 · the same entry in another collection · chain A against A, TM-score 1.00
  • P08922 · AlphaFold monomer V2.0 prediction for proto-oncogene tyrosine-protein kinase ROS (P08922) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.